Cargando…
Metformin mediates cardioprotection against aging‐induced ischemic necroptosis
Necroptosis is crucially involved in severe cardiac pathological conditions. However, whether necroptosis contributes to age‐related intolerance to ischemia/reperfusion (I/R) injury remains elusive. In addition, metformin as a potential anti‐aging related injury drug, how it interacts with myocardia...
Autores principales: | Li, Chen, Mu, Nan, Gu, Chunhu, Liu, Manling, Yang, Zheng, Yin, Yue, Chen, Mai, Wang, Yishi, Han, Yuehu, Yu, Lu, Ma, Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996959/ https://www.ncbi.nlm.nih.gov/pubmed/31944526 http://dx.doi.org/10.1111/acel.13096 |
Ejemplares similares
-
Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus
por: Li, Tian, et al.
Publicado: (2021) -
Metformin-Enhanced Cardiac AMP-Activated Protein Kinase/Atrogin-1 Pathways Inhibit Charged Multivesicular Body Protein 2B Accumulation in Ischemia–Reperfusion Injury
por: Li, Tian, et al.
Publicado: (2021) -
Changes of Necroptosis in Irbesartan Medicated Cardioprotection in Diabetic Rats
por: Xu, Qingmei, et al.
Publicado: (2021) -
Impaired Cardiac SIRT1 Activity by Carbonyl Stress Contributes to Aging-Related Ischemic Intolerance
por: Gu, Chunhu, et al.
Publicado: (2013) -
Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
por: Argun, Mustafa, et al.
Publicado: (2016)